[1] Nordin BE, Roper A.Post-pregnancy osteoporosis: a syndrome[J]. Lancet, 1955,268(6861):431-434. [2] Li LJ,Zhang J,Gao P,et al.Clinical characteristics and bisphosphonates treatment of rare pregnancy-and lactation-associated osteoporosis[J]. Clin Rheumatol, 2018,37(11):3141-3150. [3] Gehlen M, Lazarescu AD, Hinz C, et al.Pregnancy and lactation-associated osteoporosis[J]. Z Rheumatol, 2017,76(3):273-278. [4] Dunne F, Walters B, Marshall T, et al.Pregnancy associated osteoporosis[J]. Clin Endocrinol (Oxf), 1993,39(4):487-490. [5] 苏宏业,黄媛,李圣琦,等. 妊娠哺乳相关骨质疏松症[J]. 中国骨质疏松杂志, 2011,17(2):150-152. [6] 王诗玮,徐爱华,李玉姝. 妊娠哺乳相关骨质疏松症一例[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018,11(4):386-390. [7] Kovacs CS.Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery[J]. Physiol Rev,2016,96(2):449-547. [8] Elhr-Vainicher C, Ossola MW, Beck-PeccozP, et al. PTHrP associated hypercaleemia of pregnancy resolved after delivery: a case report[J]. Eur J Endocrinol, 2012, 166(4):753-756. [9] Vujasinovic Stupar N, Pejnovic N, Markovic L, et al.Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome[J]. Rheumatoi Int, 2012, 32(3):819-823. [10] Hong N, Kim JE, Lee SJ, et al.Changes in bone mineral density and hone turnover markers during treatment with teriparatide in pregnancy and lactation-associated osteopornsis[J]. Clin Endocrinol (Oxf), 2018,88(5):652-658. [11] Sefika BP, Berna E, Cevdet A, et al.Effective treatment of severe pregnancy and lactation-related osteoporosis with teriparatide: case report and review of the literature[J]. Gynecol Endocrinol, 2015, 31(7):522-525. [12] Sánchez A, Zanchetta MB, Danilowicz K.Two cases of pregnancy and lactation-associated osteoporosis successfully treated with denosumab[J]. Clin Cases Miner Bone Metabol, 2016,13(3):244-246. |